Citations

Institution: Mayo Clinic Clear

Showing 10 of 108036 citations.

Imaging in MASLD
Venkatesh, Sudhakar K.

Expert Review of Gastroenterology & Hepatology | February 20, 2026 | Volume: 20 | Issue: 3 | Pages: 257-272

10.1080/17474124.2026.2636184 | PMID 41715977 Get It

Optimizing Antimicrobial Stewardship in Hospital‐at‐Home Programs: On Behalf of the Society of Infectious Diseases Pharmacists
Pertzborn, Margaret , Peinovich, Margaret , Webster, Leah W., Cid, Allison , Ausman, Sara , Rivera, Christina G. , (SIDP), Society of Infectious Diseases Pharmacists, Webster, Leah C. Whitman , Webster, Leah Whitman , Rivera, Christina G , Ausman, Sara E

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | February 20, 2026 | Volume: 9 | Issue: 3 | Pages: No page available

10.1002/jac5.70185 | PMID 42009438 Get It

ABSTRACT Hospital‐at‐Home (HaH) programs provide acute care in patients' homes, reducing hospitalization and improving patient experience. While crucial in traditional settings, antimicrobial stewardship (AMS) in HaH programs remains understudied. This manuscript explores the potential benefits of AMS in HaH and the role of infectious diseases (ID) pharmacists in optimizing antimicrobial therapy. Key challenges in implementing AMS in HaH include medication delivery logistics, treatment regimen adjustments, and unique administration techniques. ID pharmacists can address these challenges by providing expertise in antimicrobial selection, dosing, and duration, as well as identifying opportunities for de‐escalation and intravenous (IV) to oral conversions. By integrating AMS into HaH programs, health care systems can improve patient outcomes, reduce antimicrobial resistance, and optimize resource utilization. Further research and training programs are needed to fully realize the potential of AMS in this emerging model of care.
White matter predictors of cerebellar tDCS treatment effects in aphasia rehabilitation
Keser, Zafer, Lammers, Becky , Sydnor, Myra, Murter, Jamie L., Zhang, Yiyang, Desmond, John E. , Sebastian, Rajani , Keser, Zafer , Johnson, Micah Alan , Keser, Zafer , Sadil, Patrick S. , Hillis, Argye Elizabeth , Lindquist, Martin A.

Frontiers in Neurology | February 20, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fneur.2026.1659337 | PMID 41798805 Get It

Introduction Cerebellar transcranial direct current stimulation (tDCS) combined with language therapy can aid in chronic aphasia recovery, but the neural mechanisms and biomarkers of treatment efficacy remain uncertain. Methods In this secondary analysis of data from a previously conducted clinical trial, we used a randomized, double-blind, sham-controlled, within-subject crossover design with a study sample of 19 participants with post-stroke aphasia. We assessed the degree to which baseline properties of cerebro-cerebellar white matter tracts can predict or moderate longitudinal treatment effects at three time points: post-treatment, 2 weeks post-treatment, and 2 months post-treatment. Tract properties were measured by fractional anisotropy (FA) and mean diffusivity (MD) from diffusion tensor imaging (DTI). We also tested whether there are differential effects between trained and untrained language tasks and between cerebellar tDCS polarity (anodal and cathodal). Results Baseline measures of tracts connecting the left lesioned cortex to the right posterolateral cerebellum (stimulation target) influenced treatment gains for untrained tasks, relative to sham control. In contrast, for the trained task, treatment gains were influenced by baseline measures of tracts connecting the non-stimulated left cerebellum with the contralateral right cerebral cortex. Although there were no consistent effects from cerebellar tDCS polarity, a highly consistent pattern emerged across all tasks and tracts. Specifically, language improvements were predicted by a baseline tract profile (i.e., higher FA and lower MD) typically associated with higher white matter integrity, especially within the context of stroke-induced white matter decline. Discussion These findings corroborate the potential for baseline tract properties as a biomarker of treatment efficacy and support the notion that adjuvant (cerebellar tDCS + language) therapy preferentially benefits individuals with relatively preserved structural connections within functionally relevant networks. Clinical trial registration ClinicalTrials.gov , identifier (NCT02901574).
Collections: Curated articles from the Editorial Board of Headache
Pardo, Keshet , Malhotra, Nisha Aparna , Ackley, Elizabeth , Pardo, Keshet

Headache: The Journal of Head and Face Pain | February 20, 2026 | Volume: 66 | Issue: 4 | Pages: 789-790

10.1111/head.70066 Get It

Craniofacial Hypoplasia and the Difficult Airway
Huynh, Kathleen, Gritsenko, Karina, Breidenbach, Kathryn, Diaz, Steven, Sterling, Felix Dailey, Koushik, Sarang , Viswanath, Omar, Borowski, Blaze, Lee, Kay , Huynh, Kathleen, Gritsenko, Karina , Breidenbach, Kathryn A., Viswanath, Omar , Shaparin, Naum

Orthopedic Reviews | February 19, 2026 | Volume: 18 | Issue: No issue available | Pages: No page available

10.52965/001c.157900 | PMID 41728203 Get It

Introduction Craniofacial hyperplasia is a disorder where the face and head do not fully develop. This leads to difficulties in airway management in those undergoing general anesthesia (GA), requiring consideration in anesthetic planning with GA and intubation versus approaches with regional/spinal anesthesia. Case Presentation A 54-year-old male (45 kg, 172.7 cm) presented for a penile implant insertion for severe erectile dysfunction following radical prostatectomy. He was classified as ASA physical status class III. Management and Outcomes Pertinent medical history included craniofacial hypoplasia from childhood surgical interventions and radiation for sinus cancer (rhabdomyosarcoma), moderate mitral regurgitation, mild tricuspid regurgitation, pulmonary hypertension, recurrent esophageal strictures, and anemia. Spinal anesthesia was selected over GA. Airway complications were avoided, and cardiopulmonary stability was preserved while maintaining adequate analgesic coverage. Conclusion Craniofacial hypoplasia patients require individualized anesthesia planning that anticipates complications. Spinal anesthesia can be used in these patients to avoid airway and hemodynamic complications.
Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Locoregional Gastric Adenocarcinoma
Adenocarcinoma, Expert Panel Adjuvant Therapy for Treatment of Locoregional Gastric, Tchelebi, Leila T. , Jin, Zhaohui, Attallah, Joseph, Abood, G., Akselrod, Dmitriy, Codipilly, D. Chamil, Dozois, Eric J. , Hallemeier, Christopher L., Krishan, Jethwa, Kennedy, Timothy, Lee, Percy P., Ling, Diane, Newman, Neil B. , Sharma, Navesh K, Small, William, Russo, Suzanne , Tchelebi, Leila , Jin, Zhaohui , Abood, Gerard, Akselrod, Dmitriy , Anker, Christopher J. , Codipilly, Don C. , Hallemeier, Christopher Leigh , Lee, Percy , Miller, Eric D. , Sharma, Navesh, Small, William , Russo, Suzanne

American Journal of Clinical Oncology | February 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/coc.0000000000001309 | PMID 41712927 Get It

Objectives: To summarize recent high-quality trials and provide an update to the original 2022 American College of Radiology Appropriate Use Criteria for Treatment of Locoregional Gastric Adenocarcinoma. This multi-specialty-led committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and surgical oncology. Methods: Using the population, intervention, comparator, outcome, timing, and study design framework, the evidence was assessed using Cochrane and PRISMA 2020 methodology. Eligible studies included prospective Phase II/II trials and select retrospective studies published between 5/1/2020 and 8/1/2025 in the Embase, Medline, and Pubmed databases. Study type and quality were assessed. Well-established RAND-UCLA consensus methodology (modified Delphi) was used to rate the appropriateness of the treatment options. Results: ARS AUC recommendations include adjuvant FLOT chemotherapy for localized gastric adenocarcinoma after neoadjuvant FLOT and surgery, poCT or perioperative chemoimmunotherapy for localized gastric adenocarcinoma, adjuvant chemotherapy +/− CRT for localized gastric adenocarcinoma that undergoes upfront surgery, and systemic therapy alone for localized gastric adenocarcinoma in a medically inoperable patient. Conclusions: This updated ARS AUC summary provides guidelines for the multimodality treatment of resectable gastric adenocarcinoma.
Immunotherapy in Synchronous Gastric and Colonic Deficient Mismatch Repair Malignancies in a Case Series of Patients With Lynch Syndrome
Chung, Kevin , Schwengber, Wallace Klein , Shah, Surbhi, Wasif, Nabil , Samadder, Jewel J., Zhu, Mojun , Wu, Christina, Wu, Christina , Schwengber, Wallace Klein , Samadder, N Jewel , Wu, Christina

JCO Precision Oncology | February 19, 2026 | Volume: 10 | Issue: 2 | Pages: No page available

10.1200/po-25-00433 | PMID 41712873 Get It

The Weight That Grounds Me
Mookadam, Martina, Mookadam, Martina

Family Medicine | February 19, 2026 | Volume: 58 | Issue: 3 | Pages: 232-233

10.22454/fammed.2026.924639 | PMID 42102880 Get It

Prioritizing Research Metrics in Family Medicine: A CERA Study of Department Chairs
Patel, Khyati H., Harmelink, Bennett, Merfeld, John, Stacey, Stephen K , Patel, Khyati, Harmelink, Bennett, Merfeld, John, Seehusen, Dean A.

Family Medicine | February 19, 2026 | Volume: 58 | Issue: 3 | Pages: 208-214

10.22454/fammed.2026.619937 | PMID 42102875 Get It

Background and Objectives: Despite wide agreement on the importance of building research capacity to the specialty of family medicine, no standard exists for defining or measuring that growth. Previous work to address this gap yielded the Productivity and Capacity Evaluation in Research (PACER) Tool, a list of quantitative research metrics grouped into seven categories. We surveyed family medicine department chairs to understand which categories of PACER metrics they considered most valuable in evaluating their department’s research capacity. We also aimed to compare reported research capacity in 2024 with answers given by family medicine department chairs in 2021. Methods: A cross-sectional survey administered through the Council of Academic Family Medicine Educational Research Alliance (CERA) was used to gather information from family medicine department chairs in the United States and Canada. One question asked chairs to evaluate their department’s research capacity, and nine questions assessed the relative importance of the seven PACER Tool categories. Results: A total of 218 surveys were delivered, with 111 (50.9%) completed. Survey results demonstrated that program chairs determined funding to be the most impactful category. We found no clear trend in the second most important or least important categories. Results also showed no statistically significant change in reported research capacity between 2021 and 2024. Conclusions: Funding emerged as the category of research metrics viewed as most important by the greatest number of family medicine department chairs. Although other categories of metrics also were viewed as important, this survey demonstrated no clear pattern of their relative importance in this population.
Contrast-enhanced US Evaluation of Indeterminate Focal Renal Masses
Desai, Madhura , Alexander, Lauren F. , Clingan, M. Jennings , Thompson, Cole P. , Patel, Neema , Barbee, Victoria, Cox, Kelly L., Agely, Ali , Gu, Chris N., Caserta, Melanie P. , Thompson, Cole P. , Desai, Madhura A , Clingan, Mary Jennings , Patel, Neema J, Barbee, Victoria V , Cox, Kelly L , Alexander, Lauren F , Cox, Kelly

RadioGraphics | February 19, 2026 | Volume: 46 | Issue: 3 | Pages: No page available

10.1148/rg.250103 | PMID 41712443 Get It

CEUS is a safe and cost-effective means for characterization of indeterminate renal masses, with performance equal to or better than that of contrast-enhanced CT or MRI for stratification and surveillance of cystic renal masses and discrimination of benign avascular cysts from solid renal masses.